Detalhe da pesquisa
1.
Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies.
Ann Rheum Dis
; 83(2): 177-183, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932010
2.
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
Ann Rheum Dis
; 83(4): 421-428, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071508
3.
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry.
Ann Rheum Dis
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38816065
4.
[The German COVID-19 rheumatism register]. / Das deutsche COVID-19-Rheumaregister.
Z Rheumatol
; 2024 May 30.
Artigo
em Alemão
| MEDLINE | ID: mdl-38816582
5.
Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany.
Z Rheumatol
; 83(Suppl 1): 20-30, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749363
6.
[Current data on rheumatological care: annual report from the National database (NDB) of the regional collaborative arthritis centres in Germany]. / Aktuelle Zahlen zur rheumatologischen Versorgung Jahresbericht aus der Kerndokumentation der regionalen kooperativen Rheumazentren.
Z Rheumatol
; 2024 Apr 03.
Artigo
em Alemão
| MEDLINE | ID: mdl-38568444
7.
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases.
Ann Rheum Dis
; 82(6): 742-753, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328476
8.
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries.
Ann Rheum Dis
; 82(2): 175-181, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36100351
9.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis
; 82(1): 3-18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357155
10.
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Ann Rheum Dis
; 82(6): 773-787, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953263
11.
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries.
Ann Rheum Dis
; 82(5): 698-709, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36787993
12.
Identification of rheumatoid arthritis in German claims data using different algorithms: Validation by cross-sectional patient-reported survey data.
Pharmacoepidemiol Drug Saf
; 32(5): 517-525, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36349482
13.
[Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. German version]. / Systematisches Review zur Schätzung der Prävalenz entzündlich rheumatischer Erkrankungen in Deutschland.
Z Rheumatol
; 82(9): 727-738, 2023 Nov.
Artigo
em Alemão
| MEDLINE | ID: mdl-36592211
14.
Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries.
J Dtsch Dermatol Ges
; 21(10): 1170-1176, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37653583
15.
Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register.
Ann Rheum Dis
; 81(1): 41-47, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34321218
16.
Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP).
Ann Rheum Dis
; 81(11): 1524-1533, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961759
17.
EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology.
Ann Rheum Dis
; 81(6): 780-785, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058229
18.
Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases.
Ann Rheum Dis
; 81(7): 998-1005, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338032
19.
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
Ann Rheum Dis
; 81(5): 695-709, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34972811
20.
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.
Ann Rheum Dis
; 81(10): 1358-1366, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705376